|
⚲
|
| Keyboard |
| Viret Jean-Frederic
✚
|
|
|---|---|
| CIK # | 0001427569 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001427569] | |
| 4 | [0001427569] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SpyGlass Pharma Inc | |
| Viret Jean-Frederic | |
| NGM Biopharmaceuticals Inc | |
| Coherus Oncology Inc | |
| Diadexus Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SpyGlass Pharma Inc SGP
Stock Option (right to buy) · derivative
|
2026-02-05 | Grant | 17,500 | $0.00 | |
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Tender | 3,038 | ||
|
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
|
2024-04-05 | Disposed to issuer | 450,000 | ||
|
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
|
2023-12-01 | Grant | 450,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2021-02-01 | Option exercise | 7,402 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-02-01 | Sell | 7,402 | $21.55 | 159,513 |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-02-01 | Option exercise | 7,402 | $10.05 | 74,390 |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-01-25 | Sell | 40,000 | $20.10 | 804,000 |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-01-25 | Sell | 6,144 | $19.00 | 116,736 |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2021-01-25 | Option exercise | 40,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-01-25 | Option exercise | 40,000 | $10.05 | 402,000 |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2021-01-11 | Grant | 62,500 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-01-11 | Grant | 31,250 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-01-10 | Tax withheld | 4,080 | $18.18 | 74,174 |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2020-11-17 | Sell | 1,995 | $17.49 | 34,893 |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2020-11-17 | Option exercise | 1,500 | $13.50 | 20,250 |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2020-11-17 | Option exercise | 1,500 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2020-10-14 | Sell | 6,144 | $19.00 | 116,736 |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2020-05-20 | Sell | 1,278 | $17.66 | 22,569 |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2020-02-19 | Option exercise | 3,159 | $10.05 | 31,748 |
| showing 20 of 92 most recent transactions | |||||